Invent Medic Sweden AB (XSAT:IMS) EBIT: kr-4.40 Mil (TTM As of Mar. 2026)


XSAT:IMS Invent Medic Sweden AB XSAT:IMS
38 GF Score
Price kr0.13
GF Value kr0.18
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Invent Medic Sweden AB EBIT?

Invent Medic Sweden AB XSAT:IMS 38 EBIT is kr-4.40 Mil as of Mar. 2026. GuruFocus rates XSAT:IMS with a GF Score™ of 38/100 and a GF Value™ of kr0.18 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Invent Medic Sweden AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was kr-0.78 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-4.40 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Invent Medic Sweden AB's annualized ROC % for the quarter that ended in Mar. 2026 was -36.58%. Invent Medic Sweden AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -520.17%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Invent Medic Sweden AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -24.44%.


Invent Medic Sweden AB  (XSAT:IMS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Invent Medic Sweden AB's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-3.108 * ( 1 - 0% )/( (7.775 + 9.22)/ 2 )
=-3.108/8.4975
=-36.58 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Invent Medic Sweden AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.108/( ( (0.075 + max(-0.216, 0)) + (0.062 + max(1.058, 0)) )/ 2 )
=-3.108/( ( 0.075 + 1.12 )/ 2 )
=-3.108/0.5975
=-520.17 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.044 + 0.592 + 4.4408920985006E-16) - (1.072 + 0 + 0.78)
=-0.216

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.154 + 0.453 + 4.4408920985006E-16) - (0 + 0 + 1.549)
=1.058

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Invent Medic Sweden AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-4.395/17.981
=-24.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invent Medic Sweden AB EBIT Related Terms


Invent Medic Sweden AB EBIT Historical Data

* Premium members only.

The historical data trend for Invent Medic Sweden AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invent Medic Sweden AB EBIT Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.84 -11.83 -8.15 -6.21 -4.92

Invent Medic Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.31 -1.48 -1.09 -1.05 -0.78

XSAT:IMS vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Invent Medic Sweden AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invent Medic Sweden AB EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's EV-to-EBIT falls into.


XSAT:IMS
38GF Score
Invent Medic Sweden AB XSAT:IMS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Invent Medic Sweden AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-4.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr-4.40 Mil mean?
Invent Medic Sweden AB (XSAT:IMS) has a EBIT of kr-4.40 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Invent Medic Sweden AB.
Is Invent Medic Sweden AB's EBIT too high?
Invent Medic Sweden AB's current EBIT is kr-4.40 Mil. Overall, Invent Medic Sweden AB has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Invent Medic Sweden AB's EBIT compare to ABT and SYK?
Invent Medic Sweden AB's EBIT of kr-4.40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Invent Medic Sweden AB. Invent Medic Sweden AB's current EBIT is kr-4.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.13 — trading 25.6% below its estimated fair value. The current EBIT is kr-4.40 Mil. Invent Medic Sweden AB's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current EBIT is kr-4.40 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Invent Medic Sweden AB (XSAT:IMS) Overvalued in 2026?

Based on GuruFocus' analysis, Invent Medic Sweden AB stock appears to be undervalued. The current stock price of kr0.13 is trading 25.6% below its estimated GF Value™ of kr0.18. GuruFocus considers Invent Medic Sweden AB to be Modestly Undervalued.

Key valuation signals for XSAT:IMS:

  • EBIT: kr-4.40 Mil
  • GF Value™: kr0.18 vs. price of kr0.13 (25.6% below fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the XSAT:IMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Invent Medic Sweden AB Business Description

Address Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
38GF Score

Get the complete analysis for XSAT:IMS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.13
Price
kr0.18
GF Value